Does ATEZOLIZUMAB Cause Neoplasm progression? 220 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 220 reports of Neoplasm progression have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.7% of all adverse event reports for ATEZOLIZUMAB.
220
Reports of Neoplasm progression with ATEZOLIZUMAB
0.7%
of all ATEZOLIZUMAB reports
63
Deaths
51
Hospitalizations
How Dangerous Is Neoplasm progression From ATEZOLIZUMAB?
Of the 220 reports, 63 (28.6%) resulted in death, 51 (23.2%) required hospitalization, and 13 (5.9%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATEZOLIZUMAB. However, 220 reports have been filed with the FAERS database.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which ATEZOLIZUMAB Alternatives Have Lower Neoplasm progression Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN